We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$198B
$106M 2.55%
636,678
+47,963
+8% +$8.11M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.24T
$106M 2.55%
2,639,520
+606,220
+30% +$23.7M
JNJ icon
3
Johnson & Johnson
JNJ
$603B
$88.9M 2.14%
752,866
+23,922
+3% +$2.9M
PEP icon
4
PepsiCo
PEP
$184B
$72.4M 1.74%
665,302
+10,333
+2% +$1.11M
AMZN icon
5
Amazon
AMZN
$2.66T
$71.9M 1.73%
1,716,520
+26,920
+2% +$1.03M
AAPL icon
6
Apple
AAPL
$4.81T
$71.7M 1.72%
2,535,456
+194,820
+8% +$5.16M
GILD icon
7
Gilead Sciences
GILD
$162B
$66.6M 1.6%
842,044
-72,140
-8% -$5.86M
META icon
8
Meta Platforms (Facebook)
META
$1.63T
$62.2M 1.5%
485,051
+54,722
+13% +$6.79M
XOM icon
9
ExxonMobil
XOM
$629B
$60.5M 1.46%
693,495
+61,264
+10% +$5.44M
BIIB icon
10
Biogen
BIIB
$30B
$58.1M 1.4%
185,717
+19,856
+12% +$5.88M
CSCO icon
11
Cisco
CSCO
$442B
$55.6M 1.34%
1,752,634
+129,197
+8% +$3.97M
MSFT icon
12
Microsoft
MSFT
$2.95T
$48.4M 1.16%
839,732
-31,872
-4% -$1.8M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$70.8B
$42.7M 1.03%
106,210
+11,106
+12% +$4.46M
T icon
14
AT&T
T
$155B
$42.6M 1.03%
1,390,354
+81,523
+6% +$2.58M
PG icon
15
Procter & Gamble
PG
$345B
$38.1M 0.92%
424,906
-309,659
-42% -$26.9M
VZ icon
16
Verizon
VZ
$183B
$37.7M 0.91%
725,048
+12,858
+2% +$690K
INCY icon
17
Incyte
INCY
$23.5B
$37.1M 0.89%
393,804
+55,743
+16% +$4.7M
CELG
18
DELISTED
Celgene Corp
CELG
$36.7M 0.88%
351,254
-88,808
-20% -$9.61M
BABA icon
19
Alibaba
BABA
$283B
$34.9M 0.84%
330,258
+27,970
+9% +$2.59M
PFE icon
20
Pfizer
PFE
$142B
$34.4M 0.83%
1,070,361
-346,258
-24% -$11.6M
CNI icon
21
Canadian National Railway
CNI
$77.1B
$34M 0.82%
520,911
+477,985
+1,114% +$30.2M
MMM icon
22
3M
MMM
$89.1B
$31.8M 0.76%
215,579
-45,644
-17% -$6.81M
JPM icon
23
JPMorgan Chase
JPM
$918B
$30.7M 0.74%
461,713
-35,728
-7% -$2.33M
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
$30.5M 0.73%
386,092
+70,110
+22% +$5.98M
MRK icon
25
Merck
MRK
$312B
$30.5M 0.73%
511,841
+96,037
+23% +$5.62M

Similar funds

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.